Tag: Treatments
-
Enhancing Safety and Accessibility in Blood Cancer Treatments Through Technological Advances
Emerging tests and treatment strategies guide more tailored approaches and ease the burden on patients ORLANDO, Fla., Dec. 6, 2025 /PRNewswire/ — Four clinical trials to be presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition illustrate how advancements in technology are contributing to an improved outlook for many patients with…
-
Enhancing Safety and Access to Blood Cancer Treatments Through Technological Advances
Continuous and Fixed-Duration Treatments Result in Similar Outcomes for CLLÂ 1: Fixed-duration versus continuous targeted treatment for previously untreated chronic lymphocytic leukemia: Results from the randomized CLL17 trial According to a new trial, patients with chronic lymphocytic leukemia (CLL) show comparable outcomes whether they receive a single-agent treatment indefinitely or a combination treatment for a fixed…